Healthcare

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 29, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 28, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 27, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 26, 2020.
Abbott released a positive interim analysis of an ongoing clinical study assessing the accuracy of its ID NOW COVID-19 rapid that showed the test that can provide results within 15 minutes has a high degree of specificity and sensitivity.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 22, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 21, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 20, 2020.
A research study in mice by investigators at the University of Rochester Medical Center suggests it would be possible to repair the brain cell damage caused by multiple sclerosis.
Research conducted under the collaboration will support FDA objectives to explore the natural history of the disease, as well as treatment and diagnostic patterns through the use of relevant and new data sources.
PRESS RELEASES